- Report
- September 2023
- 122 Pages
North America
From €1432EUR$1,500USD£1,199GBP
- Drug Pipelines
- September 2020
- 737 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- February 2022
- 138 Pages
Global
From €14311EUR$14,995USD£11,991GBP
- Report
- April 2022
- 80 Pages
Africa
From €1909EUR$2,000USD£1,599GBP
- Report
- April 2022
- 40 Pages
Brazil
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
China
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
France
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Germany
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
India
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Ireland
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 100 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- January 2024
- 185 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- January 2024
- 26 Pages
Global
€16368EUR$17,150USD£13,714GBP
- Report
- March 2019
- 39 Pages
Global
€9544EUR$10,000USD£7,996GBP

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more